UK Healthcare And Pharmaceutical Market Regulatory & Reimbursement Landscape Report Till 2020 GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the UK. The report identifies the key trends in the healthcare market and provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts. In 2014, the UK`s population was approximately 64.2 million. The major factors contributing to the growth in the population are increase in net migration and decrease in death rate. The UK policymakers are now presented with the problems of a Eurozone crisis, a declining population of the working age group and an increasing elderly population. The pharmaceutical market in the UK was estimated at $28.8 billion in 2015 and is expected to reach approximately $43.2 billion by 2020 with a projected Compound Annual Growth Rate (CAGR) of 8.4%. The medical devices market size was approximately $14.4 billion in 2015 and is expected to reach approximately $17.9 billion by 2020 with a projected CAGR of 4.5%. To Get More Details @ http://www.radiantinsights.com/research/countryfocus-healthcareregulatory-and-reimbursement-landscape-uk The positive trends in the UK healthcare market can be attributed primarily to - Increasing elderly population - Universal healthcare insurance - High degree of access to healthcare facilities Scope The report provides information on the healthcare, regulatory and reimbursement landscape of the UK. The scope includes - Overview of the pharmaceutical and medical devices market of the UK including the market size, market segmentation, key drivers and barriers. - Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, GlaxoSmithKline, Novartis, Roche and Merck. The key players covered for the medical devices market are Essilor International, GlaxoSmithKline, DePuy Companies, Johnson & Johnson and B.Braun. - Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices.
- A detailed analysis of the political and economic environment of the UK including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure. - An overview of the opportunities and challenges for growth that exist in the healthcare market of the UK. Reasons to buy The report on the UK comprehensively covers both the pharmaceutical and the medical devices markets of the UK. The report will enhance your decision making capability. It will allow you to - Develop business strategies by understanding the trends shaping and driving the healthcare market of the UK. - Drive revenue by understanding the key trends, and reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the the UK healthcare market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the various competitors. - Organize your sales and marketing efforts by identifying the market categories and segments that present the maximum opportunities for consolidations, investments and strategic partnerships. - Identify, understand and capitalize on the opportunities and challenges in the healthcare market of the UK. Request Free Sample Of This Study @ http://www.radiantinsights.com/research/countryfocus-healthcare-regulatory-andreimbursement-landscape-uk#tabs-4 Table Of Content: 1 Table of Contents 6 1.1 List of Tables 9 1.2 List of Figures 13 2 Introduction 18 2.1 GlobalData Report Guidance 18 3 Overview of the Pharmaceutical and Medical Device Markets 19 3.1 Pharmaceutical Market 19 3.1.1 Market Overview 19 3.1.2 Pharmaceutical Exports and Imports 21 3.1.3 Supply Channels 22 3.1.4 Market Segments 24
3.1.5 Major Therapeutic Areas 26 3.1.6 Major Companies 32 3.2 Medical Device Market 76 3.2.1 Market Overview 76 3.2.2 Overview of Top Five Segments 78 3.2.3 Diagnostic market 89 3.2.4 Major Players 92 3.3 Market Drivers and Barriers 122 3.3.1 Drivers 122 3.3.2 Barriers 123 4 Market Access 125 4.1 Reimbursement and Payer Landscape 125 4.1.1 Overview of Healthcare System 125 4.1.2 Reimbursement Process 129 4.1.3 Overview of Insurance Providers 131 4.1.4 Patient Share in Healthcare Spending 133 4.1.5 Drug Price Change 134 4.1.6 Pricing Policies 135 4.2 Regulatory Landscape 136 4.2.1 Overview of Regulatory Agencies 136 4.2.2 Market Authorization Procedure for Pharmaceutical Products 138 4.2.3 New Medical Device Approval Process 149 4.2.4 Licensing Process for Pharmaceutical Manufacturing 156 4.2.5 Intellectual Property Rights 157 Browse All Reports of This Category @ http://www.radiantinsights.com/catalog/medicaldevices 4.2.6 Clinical Trial Regulations 159 4.2.7 Pharmaceutical Advertising Regulations 162 4.2.8 Pharmacy Regulations 163 4.2.9 Labeling and Packaging Regulations 164 5 Country Analysis 166 5.1 Political Environment 166 5.1.1 Political Structure 166 5.1.2 Analysis of the Current Political Environment 167 5.1.3 Healthcare Policy Initiatives 169 5.2 Economic Landscape 170 5.3 Economic Indicators 171 5.3.1 Gross Domestic Product 171 5.3.2 Gross National Income 175
5.3.3 Inflation 176 5.3.4 Currency Exchange Rate 179 5.3.5 Foreign Direct Investment 181 5.3.6 Foreign Exchange Reserves 182 5.3.7 Trade Balance 183 5.3.8 Government Structural Balance 185 5.3.9 General Government Gross Debt 186 5.3.10 External Debt 188 5.3.11 Major Industries 189 5.4 Demographics 190 5.4.1 Population 190 5.4.2 Education and Literacy 206 5.4.3 Employment 208 5.4.4 Disease Burden 209 5.5 Healthcare Infrastructure 211 5.5.1 Healthcare Facilities 211 5.5.2 Healthcare Parameters 213 5.5.3 Environmental Health 215 5.5.4 Healthcare Personnel 220 5.6 Healthcare Expenditure 223 5.6.1 Overview 223 5.6.2 Components of Healthcare Spending 224 5.6.3 Public and Private Sector Share 226 5.6.4 Spending in Pharmaceutical R&D 227 Browse full report on: http://www.radiantinsights.com/research/countryfocus-healthcareregulatory-and-reimbursement-landscape-uk 5.7 Trade Associations 229 5.7.1 Association of the British Pharmaceutical Industry (ABPI) 229 5.7.2 British In Vitro Diagnostics Association (BIVDA) 229 5.7.3 National Pharmacy Association (NPA) 229 5.7.4 Association of British Healthcare Industries (ABHI) 230 5.7.5 British Generic Manufacturers Association (BGMA) 230 5.8 Trade Fairs 230 6 Opportunities and Challenges 232 6.1 Opportunities 232 6.2 Challenges 233 7 Appendix 235 7.1 Abbreviations 235 7.2 Bibliography 239
7.3 Research Methodology 250 7.3.1 Coverage 250 7.3.2 Secondary Research 250 7.3.3 Forecasts 251 7.3.4 Expert Panel 251 7.4 Disclaimer 252 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com